161 related articles for article (PubMed ID: 15084968)
1. Serum tumor markers and molecular biological diagnosis in pancreatic cancer.
Sawabu N; Watanabe H; Yamaguchi Y; Ohtsubo K; Motoo Y
Pancreas; 2004 Apr; 28(3):263-7. PubMed ID: 15084968
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay.
Watanabe H; Yamaguchi Y; Ha A; Hu YX; Motoo Y; Okai T; Yoshimura T; Sawabu N
Pancreas; 1998 Nov; 17(4):341-7. PubMed ID: 9821175
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma.
Ha A; Watanabe H; Yamaguchi Y; Ohtsubo K; Wang Y; Motoo Y; Okai T; Wakabayahi T; Sawabu N
Pancreas; 2001 Nov; 23(4):356-63. PubMed ID: 11668203
[TBL] [Abstract][Full Text] [Related]
4. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.
Watanabe H; Ha A; Hu YX; Ohtsubo K; Yamaguchi Y; Motoo Y; Okai T; Toya D; Tanaka N; Sawabu N
Cancer; 1999 Oct; 86(8):1441-8. PubMed ID: 10526271
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of tumor markers associated with pancreatic cancer].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
[TBL] [Abstract][Full Text] [Related]
7. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
[TBL] [Abstract][Full Text] [Related]
8. Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Motoo Y; Sawabu N
Pancreas; 2004 Jan; 28(1):13-9. PubMed ID: 14707724
[TBL] [Abstract][Full Text] [Related]
9. [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):741-4. PubMed ID: 16255879
[TBL] [Abstract][Full Text] [Related]
10. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma.
Ohtsubo K; Watanabe H; Yao F; Okada G; Mouri H; Yamaguchi Y; Sawabu N
J Gastroenterol; 2006 Aug; 41(8):791-7. PubMed ID: 16988769
[TBL] [Abstract][Full Text] [Related]
11. Significance of K-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer.
Futakawa N; Kimura W; Yamagata S; Zhao B; Ilsoo H; Inoue T; Sata N; Kawaguchi Y; Kubota Y; Muto T
J Hepatobiliary Pancreat Surg; 2000; 7(1):63-71. PubMed ID: 10982594
[TBL] [Abstract][Full Text] [Related]
12. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
Lu X; Xu T; Qian J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
[TBL] [Abstract][Full Text] [Related]
13. Pancreatitis-associated protein levels in pancreatic juice from patients with pancreatic diseases.
Motoo Y; Watanabe H; Yamaguchi Y; Xie MJ; Mouri H; Ohtsubo K; Okai T; Wakabayashi T; Sawabu N
Pancreatology; 2001; 1(1):43-7. PubMed ID: 12120267
[TBL] [Abstract][Full Text] [Related]
14. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
15. Genetic diagnosis of pancreatic cancer.
Mizumoto K; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages.
Matsumoto S; Harada H; Tanaka J; Ochi K; Seno T; Tsurumi T; Kunichika K
Pancreas; 1994 Nov; 9(6):741-7. PubMed ID: 7846018
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
